CervoMed Inc. Cash and Cash Equivalents, Period Increase (Decrease)
CervoMed Inc. (CRVO) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$3.35 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-11.
Discontinued › Cash Flow
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2020-05-11
- CervoMed Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2020-03-31 was -$3.35M.
- CervoMed Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-12-31 was $8.04M.
- CervoMed Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-09-30 was -$2.23M.
- CervoMed Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-06-30 was $3.04M.
- CervoMed Inc. cash and cash equivalents, period increase (decrease) for fiscal 2019 was $6.19M.
- CervoMed Inc. cash and cash equivalents, period increase (decrease) for fiscal 2018 was -$905.30K, a 112.33% decline from fiscal 2017.
- CervoMed Inc. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $7.34M.
- CervoMed Inc. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$444.34K.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 3 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2020-03-31 | -$3.35M 10-Q · filed 2020-05-11 | $4.69M derived: sum of 2 quarters · filed 2020-05-11 | $2.46M derived: sum of 3 quarters · filed 2020-05-11 | $5.49M derived: sum of 4 quarters · filed 2020-05-11 | ||||
| 2019-12-31 | $8.04M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | $5.80M derived: sum of 2 quarters · filed 2020-03-17 | $8.84M derived: sum of 3 quarters · filed 2020-03-17 | $6.19M 10-K · filed 2020-03-17 | ||||
| 2019-09-30 | -$2.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $806.06K derived: sum of 2 quarters · filed 2019-11-08 | -$1.85M 10-Q · filed 2019-11-08 | -$4.88M derived: sum of 4 quarters · filed 2020-05-11 | ||||
| 2019-06-30 | $3.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $381.57K 10-Q · filed 2019-08-08 | -$2.65M derived: sum of 3 quarters · filed 2020-05-11 | -$4.56M derived: sum of 4 quarters · filed 2020-05-11 | ||||
| 2019-03-31 | -$2.66M 10-Q · filed 2020-05-11 | -$5.68M derived: sum of 2 quarters · filed 2020-05-11 | -$7.60M derived: sum of 3 quarters · filed 2020-05-11 | -$10.87M derived: sum of 4 quarters · filed 2020-05-11 | ||||
| 2018-12-31 | -$3.03M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | -$4.94M derived: sum of 2 quarters · filed 2020-03-17 | -$8.21M derived: sum of 3 quarters · filed 2020-03-17 | -$905.30K 10-K · filed 2020-03-17 | ||||
| 2018-09-30 | -$1.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$5.18M derived: sum of 2 quarters · filed 2019-11-08 | $2.12M 10-Q · filed 2019-11-08 | $9.80M derived: sum of 4 quarters · filed 2019-11-08 | ||||
| 2018-06-30 | -$3.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $4.04M 10-Q · filed 2019-08-08 | $11.72M derived: sum of 3 quarters · filed 2019-08-08 | $5.52M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | $7.30M 10-Q · filed 2019-05-09 | $14.98M derived: sum of 2 quarters · filed 2019-05-09 | $8.79M derived: sum of 3 quarters · filed 2019-05-09 | $3.99M derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | $7.68M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-19 | $1.48M derived: sum of 2 quarters · filed 2019-03-19 | -$3.32M derived: sum of 3 quarters · filed 2019-03-19 | $7.34M 10-K · filed 2019-03-19 | ||||
| 2017-09-30 | -$6.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$11.00M derived: sum of 2 quarters · filed 2018-11-13 | -$336.85K 10-Q · filed 2018-11-13 | -$1.81M derived: sum of 4 quarters · filed 2018-11-13 | ||||
| 2017-06-30 | -$4.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | $5.86M 10-Q · filed 2018-08-10 | $4.39M derived: sum of 3 quarters · filed 2018-08-10 | $4.41M derived: sum of 4 quarters · filed 2018-08-10 | ||||
| 2017-03-31 | $10.66M 10-Q · filed 2018-05-10 | $9.19M derived: sum of 2 quarters · filed 2018-05-10 | $9.21M derived: sum of 3 quarters · filed 2018-05-10 | $6.35M derived: sum of 4 quarters · filed 2018-05-10 | ||||
| 2016-12-31 | -$1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | -$1.45M derived: sum of 2 quarters · filed 2018-04-02 | -$4.31M derived: sum of 3 quarters · filed 2018-04-02 | -$444.34K 10-K · filed 2018-04-02 | ||||
| 2016-09-30 | $15.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | -$2.84M derived: sum of 2 quarters · filed 2017-11-13 | $1.02M 10-Q · filed 2017-11-13 | $1.12M derived: sum of 4 quarters · filed 2017-11-13 | ||||
| 2016-06-30 | -$2.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $1.01M 10-Q · filed 2017-08-14 | $1.10M derived: sum of 3 quarters · filed 2017-08-14 | $118.17K derived: sum of 4 quarters · filed 2017-08-14 | ||||
| 2016-03-31 | $3.87M 10-Q · filed 2017-05-15 | $3.96M derived: sum of 2 quarters · filed 2017-05-15 | $2.98M derived: sum of 3 quarters · filed 2017-05-15 | $1.97M derived: sum of 4 quarters · filed 2017-05-15 | ||||
| 2015-12-31 | $93.65K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | -$890.78K derived: sum of 2 quarters · filed 2017-03-31 | -$1.90M derived: sum of 3 quarters · filed 2017-03-31 | -$339.33K 10-K · filed 2017-03-31 | -$9.88M 10-K · filed 2016-03-25 | |||
| 2015-09-30 | -$984.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$1.99M derived: sum of 2 quarters · filed 2016-11-14 | -$432.98K 10-Q · filed 2016-11-14 | -$7.30M 10-Q · filed 2015-11-12 | -$2.34M derived: sum of 4 quarters · filed 2016-11-14 | |||
| 2015-06-30 | -$1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $551.46K 10-Q · filed 2016-08-15 | -$5.41M 10-Q · filed 2015-08-12 | -$1.35M derived: sum of 3 quarters · filed 2016-08-15 | -$4.70M derived: sum of 4 quarters · filed 2016-08-15 | |||
| 2015-03-31 | $1.56M 10-Q · filed 2016-05-16 | -$2.67M 10-Q · filed 2015-05-11 | -$345.41K derived: sum of 2 quarters · filed 2016-05-16 | -$3.70M derived: sum of 3 quarters · filed 2016-05-16 | $23.22M derived: sum of 4 quarters · filed 2016-05-16 | |||
| 2014-12-31 | -$1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | -$5.26M derived: sum of 2 quarters · filed 2016-03-25 | $21.66M derived: sum of 3 quarters · filed 2016-03-25 | $21.63M 10-K · filed 2016-03-25 | ||||
| 2014-09-30 | -$3.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $23.57M derived: sum of 2 quarters · filed 2015-11-12 | $23.53M 10-Q · filed 2015-11-12 | $23.53M derived: sum of 4 quarters · filed 2015-11-12 | ||||
| 2014-06-30 | $26.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $26.88M 10-Q · filed 2015-08-12 | $26.88M derived: sum of 3 quarters · filed 2015-08-12 | $27.06M derived: sum of 4 quarters · filed 2015-08-12 | ||||
| 2014-03-31 | -$32.89K 10-Q · filed 2015-05-11 | -$33.52K derived: sum of 2 quarters · filed 2015-05-11 | $143.47K derived: sum of 3 quarters · filed 2015-05-11 | $110.64K derived: sum of 4 quarters · filed 2015-05-11 | ||||
| 2013-12-31 | -$632.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-03 | $176.37K derived: sum of 2 quarters · filed 2015-04-03 | $143.53K derived: sum of 3 quarters · filed 2015-04-03 | -$57.13K 10-K · filed 2015-04-03 | ||||
| 2013-09-30 | $177.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $144.16K derived: sum of 2 quarters · filed 2014-11-12 | -$56.50K 10-Q · filed 2014-11-12 | $98.68K derived: sum of 4 quarters · filed 2014-11-12 | ||||
| 2013-06-30 | -$32.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$233.49K 10-Q · filed 2014-08-14 | -$78.31K derived: sum of 3 quarters · filed 2014-08-14 | $35.66K derived: sum of 4 quarters · filed 2014-08-14 | ||||
| 2013-03-31 | -$200.66K 10-Q · filed 2014-05-20 | -$45.48K derived: sum of 2 quarters · filed 2014-05-20 | $68.50K derived: sum of 3 quarters · filed 2014-05-20 | $98.26K derived: sum of 4 quarters · filed 2014-05-20 | ||||
| 2012-12-31 | $155.18K derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-04-23 | $269.16K derived: sum of 2 quarters · filed 2014-04-23 | $298.92K derived: sum of 3 quarters · filed 2014-04-23 | $213.64K 10-K/A · filed 2014-04-23 | ||||
| 2012-09-30 | $113.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-19 | $143.74K derived: sum of 2 quarters · filed 2013-11-19 | $58.46K 10-Q · filed 2013-11-19 | -$1.97M derived: sum of 4 quarters · filed 2013-11-19 | ||||
| 2012-06-30 | $29.76K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-08-14 | -$55.52K 10-Q · filed 2013-08-14 | -$2.09M derived: sum of 3 quarters · filed 2013-08-14 | -$5.82M derived: sum of 4 quarters · filed 2013-08-14 | ||||
| 2012-03-31 | -$85.28K 10-Q/A · filed 2013-05-20 | -$2.12M derived: sum of 2 quarters · filed 2013-05-20 | -$5.85M derived: sum of 3 quarters · filed 2013-05-20 | |||||
| 2011-12-31 | -$2.03M derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-04-24 | -$5.77M derived: sum of 2 quarters · filed 2013-04-24 | $98.45K 10-K/A · filed 2013-04-24 | |||||
| 2011-09-30 | -$3.74M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-19 | $2.13M 10-Q · filed 2012-11-19 | ||||||
| 2011-06-30 | $5.87M 10-Q/A · filed 2012-09-07 | |||||||
| 2010-09-30 | -$45.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-21 | $13.02K 10-Q · filed 2011-11-21 | ||||||
| 2010-06-30 | $58.29K 10-Q · filed 2011-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |